2023-12-23 00:00:59
Through an in-depth review, Federal Commission for the Protection Against Sanitary Risks (Cofepris) identified 11 new distributors of irregular medications. All of them fail to comply with health regulations and were therefore closed. In addition to operating irregularly, their work also puts the integrity of the population at risk.
In that sense, an obligation for all companies that are part of the health field is to comply with all the current regulations. Various procedures are required but all have the objective of guaranteeing that the products and services are optimal and do not generate serious adverse effects.
Cofepris detects irregular drug distributors
Among the most common irregularities that occur are the sale of false medical supplies without health registration in the country, as well as deficiencies in the infrastructure for the correct storage of medications, among others.
Based on the above, Cofepris published a list of irregular drug distributors that were identified throughout the national territory.
Pharmadrug – Guanajuato Pharmaceutical Products Rivera and Manuel Oñate Flores – Guanajuato Efarma Medical Center, Special Education and Marketer of Specialized Drugs – State of Mexico Farmacéutica Levyda – State of Mexico Kalos Distributor – Aguascalientes Grupo Gadau – Mexico City Chase Farmacéutical Group – Jalisco Farmacia Los Arcos/Gloria Erika Morales Aviña – Nayarit Medication Distributor/Ethel Fonseca Ramírez – Puebla Gamro Distributor – Tabasco
Cofepris detected that, of these irregular distributors of medicines, 10 had an operating notice registered with this regulatory agency, but upon carrying out verification visits it was found that the addresses are not warehouses, but rather residential homes. In some cases, the addresses indicated in the operating notice do not exist.
This commission urges buyers of medicines and users of health supplies to avoid purchasing drugs in the indicated establishments.
Likewise, it is recommended to verify that distributors have a health manager and legal documentation that guarantees the safety and quality of the products, such as an operating notice and health license.
Cofepris maintains strict surveillance throughout the national territory to verify that companies do not violate current health regulations and, in an exercise of total transparency, periodically updates and publishes the list of irregular distributors, which in the last update includes 139 establishments. , which can be consulted in the following section: Platform for irregular drug distributors.
The danger of counterfeit medicines
It is important to remember that one of the most serious problems that has not yet been resolved is the marketing of apocryphal drugs. According to the World Health Organization (WHO), at least one in 10 on the market are counterfeit.
The above situation is a serious crime that governments must combat because people’s health is violated. Furthermore, it is estimated that this illegal activity generates profits of 150 million dollars annually on the black market.
Also read:
Doctors explain the origin of rare reactions in the human body
The rarest medical cases of 2023: They are all unique and quite rare
Healthy Christmas: Guide to enjoy without putting your well-being at risk
#Cofepris #identifies #irregular #drug #distributors #Complete #list